Jeffrey van Senten

20152019
If you made any changes in Pure these will be visible here soon.

Personal profile

Ancillary activities

No ancillary activities

Ancillary activities are updated daily

Fingerprint Dive into the research topics where Jeffrey van Senten is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Single-Domain Antibodies Medicine & Life Sciences
Chemokine Receptors Medicine & Life Sciences
Glioblastoma Medicine & Life Sciences
Photochemotherapy Medicine & Life Sciences
Viral Proteins Medicine & Life Sciences
G-Protein-Coupled Receptors Medicine & Life Sciences
Photosensitizing Agents Medicine & Life Sciences
Cytomegalovirus Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2015 2019

Nanobody-Targeted Photodynamic Therapy Selectively Kills Viral GPCR-Expressing Glioblastoma Cells

De Groof, T. W. M., Mashayekhi, V., Fan, T. S., Bergkamp, N. D., Toraño, J. S., Van Senten, J. R., Heukers, R., Smit, M. J. & Oliveira, S., 1 Jan 2019, In : Molecular Pharmaceutics.

Research output: Contribution to JournalArticleAcademicpeer-review

Single-Domain Antibodies
Photochemotherapy
Viral Proteins
Glioblastoma
G-Protein-Coupled Receptors

The constitutive activity of the virally encoded chemokine receptor US28 accelerates glioblastoma growth

Heukers, R., Fan, T. S., de Wit, R. H., van Senten, J. R., de Groof, T. W. M., Bebelman, M. P., Lagerweij, T., Vieira, J., de Munnik, S. M., Smits-de Vries, L., van Offenbeek, J., Rahbar, A., van Hoorick, D., Söderberg-Naucler, C., Würdinger, T., Leurs, R., Siderius, M., Vischer, H. F. & Smit, M. J., 30 Apr 2018, In : Oncogene. 2018, p. 1-12 12 p.

Research output: Contribution to JournalArticleAcademicpeer-review

Open Access
Chemokine Receptors
Glioblastoma
Cytomegalovirus
Single-Domain Antibodies
Growth

Human cytomegalovirus encoded chemokine receptor US28 activates the HIF-1 alpha/PKM2 axis in glioblastoma cells.

de Wit, R. H., Mujic-Delic, A., van Senten, J. R., Fraile-Ramos, A., Siderius, M. H. & Smit, M. J., 2016, In : Oncotarget. Sept 1, 11817.

Research output: Contribution to JournalArticleAcademicpeer-review

Open Access

Pharmacological characterization of [3H]VUF11211, a novel radiolabeled small-molecule inverse agonist for the chemokine receptor CXCR3

Scholten, D. J., Wijtmans, M., van Senten, J. R., Custers, H., Stunnenberg, A., de Esch, I. J. P., Smit, M. J. & Leurs, R., Apr 2015, In : Molecular Pharmacology. 87, 4, p. 639-48 10 p.

Research output: Contribution to JournalArticleAcademicpeer-review

Chemokine Receptors
Pharmacology
Ligands
CXC Chemokines
5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-ethylpiperazin-1-yl)-N-ethylnicotinamide